Our Mission
NGoggle’s goal is to promote neurodiagnostics and treatment with non-invasive BCI. We envision wearable BCI systems to monitor and expedite the diagnosis and treatment of neurodegenerative diseases.
The Company’s aim is to license its NeuroDX platform – an embedded EEG Virtual Reality (VR) head mount device for neuro-stimulation and feedback.
Based in San Diego, NGoggle is “consumerizing” BCI one obstacle at at time: it holds several patents in the miniaturization of sensors, software noise / artifact removal techniques, and machine/deep learning algorithms for detecting and tracking ophthalmic disease progression.
Our Founders
(CEO), SB-EE, MBA
Kye Cheung
Founder of several companies Graphiti, CommASIC, NeoPoint, and previously President of Impeto Medical
MD, PhD
Felipe A. Medeiros
• Vice Chair Department of Ophthalmology, Duke University
• Advisory Board Member, World Glaucoma Association
PhD, SMIEEE
John K. Zao
• Associate Director, UCSD Swartz Center for Computational Neuroscience
• Founder, SoftMax & SigMed
Our Advisors
Board Observer
Kfir Azoulay
• VP/ Head of Corporate Strategy at Heidelberg Engineering
PhD FIEEE
Tzzy-Ping Jung
Associate Director, UCSD Swartz Center for Computational Neuroscience
Founder, SoftMax & SigMed